{
    "info": {
        "nct_id": "NCT03459729",
        "official_title": "PK Analysis of Antitumor B in Patients With Oral Cancer",
        "inclusion_criteria": "* Clinical diagnosis of oral cavity squamous cell cancer.\n* Patient can start study agent administration but histological confirmation of squamous cell cancer (SCC) of the oral cavity (or histologic variants of SCC) by the pathologist must happen within 7 days of registration in order to continue study agent administration.\n* Clinical stage II-IVA (as defined by the American Joint Committee on Cancer, 8th Edition [see Amin, 2017]) and amenable to surgical resection\n* New diagnosis of oral SCC, new second primary, or recurrent oral SCC following a minimum remission of 6 months following previous definite surgery\n* History and physical examination by an otolaryngologist and medical oncologist within 14 calendar days of study registration\n* Study agent administration should start within 7 days of registration\n* Patient must receive administration of study agent for a minimum of 7 days\n* Zubrod Score/Eastern Cooperative Oncology Group (ECOG) Performance status < 2.\n* Age ≥ 18 years.\n* Complete Blood Count (CBC)/differential obtained within 14 calendar days prior to registration, with adequate bone marrow function defined as follows:\n\n  * Absolute neutrophil count (ANC) ≥ 1,500 cells/mm^3;\n  * Platelets ≥ 100,000 cells/mm^3;\n  * Hemoglobin ≥ 8.0 g/dl (Note: The use of transfusion or other intervention to achieve Hgb ≥ 8.0 g/dl is acceptable.);\n* Adequate renal and hepatic function within 14 calendar days prior to registration, defined as follows:\n\n  o Serum creatinine < 1.5 mg/dl or creatinine clearance (CCr) ≥ 50 ml/min within 14 calendar days prior to registration, determined by 24-hour collection or estimated by Cockcroft-Gault formula: CCr male = [(140 - age) x (wt in kg)] [(Serum Cr mg/dl) x (72)] CCr female = 0.85 x (CrCl male)\n* Total bilirubin < 2 x the institutional upper limit of normal (ULN) within 14 calendar days prior to registration\n* Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) ≤ 3 x the institutional ULN within 14 calendar days prior to registration\n* Magnesium, calcium, glucose, potassium, and sodium within 14 calendar days prior to registration, with the following required parameters:\n\n  * Magnesium: > 0.9 mg/dl or < 3 mg/dl;\n  * Calcium: > 7 mg/dl or < 12.5 mg/dl;\n  * Glucose: > 40 mg/dl or < 250 mg/dl;\n  * Potassium: > 3 mmol/L or < 6 mmol/L;\n  * Sodium: > 130 mmol/L or < 155 mmol/L.\n* Female patients must meet one of the following:\n\n  * Postmenopausal for at least one year before the screening visit, or\n  * Surgically sterile (e.g., undergone a hysterectomy or bilateral oophorectomy), or\n  * If the subject is of childbearing potential (defined as not satisfying either of the above two criteria), agree to practice two acceptable methods of contraception (combination methods requires use of two of the following: diaphragm with spermicide, cervical cap with spermicide, contraceptive sponge, male or female condom, hormonal contraceptive) from the time of signing of the informed consent form through 90 days after the last dose of study agent, AND\n  * Agree to practice true abstinence when this is in line with the preferred and usual lifestyle of the subject. (Periodic abstinence [e.g., calendar, ovulation, symptothermal, postovulation methods] and withdrawal are not acceptable contraception methods.)\n* Male patients, even if surgically sterilized (e.g., status post vasectomy), must agree to one of the following:\n\n  * Practice effective barrier contraception during the entire study period and through 60 calendar days after the last dose of study agent, OR\n  * Must also adhere to the guidelines of any study-specific pregnancy prevention program, if applicable, OR\n  * Agree to practice true abstinence when this is in line with the preferred and usual lifestyle of the subject. (Periodic abstinence [e.g., calendar, ovulation, symptothermal, post ovulation methods] and withdrawal are not acceptable methods of contraception.)\n* Patients must be deemed able to comply with the study plan.\n* Gastric tube study agent administration is permissible.\n* Patients must provide study-specific informed consent prior to study entry.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* History of active liver disease\n* Pregnant or lactating women are ineligible due to unforeseeable risks to embryo or fetus.\n* Concurrent use of any medicinal botanical, natural, or other herbal compound/s that the study PI believes could potentially impact the results/objectives of this study\n* Planned subtotal or debulking surgery, as determined by enrolling physician determination, is not permissible.\n* Prior systemic chemotherapy for oral SCC; note that prior chemotherapy for a different cancer is allowable.\n* Prior radiotherapy for oral SCC is permissible if disease free for 1 year since prior oral cancer treatment and free of significant late radiation effects.\n* Severe active comorbidity such as uncontrolled cardiac disease, infection, severe Chronic Obstructive Pulmonary Disease (COPD).",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Study agent administration should start within 7 days of registration",
            "criterions": [
                {
                    "exact_snippets": "Study agent administration should start within 7 days of registration",
                    "criterion": "study agent administration start time",
                    "requirements": [
                        {
                            "requirement_type": "time from registration to start",
                            "expected_value": {
                                "operator": "<=",
                                "value": 7,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Age ≥ 18 years.",
            "criterions": [
                {
                    "exact_snippets": "Age ≥ 18 years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Practice effective barrier contraception during the entire study period and through 60 calendar days after the last dose of study agent, OR",
            "criterions": [
                {
                    "exact_snippets": "Practice effective barrier contraception during the entire study period and through 60 calendar days after the last dose of study agent",
                    "criterion": "contraception method",
                    "requirements": [
                        {
                            "requirement_type": "type",
                            "expected_value": "effective barrier contraception"
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": "entire study period and through 60 calendar days after the last dose of study agent"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Agree to practice true abstinence when this is in line with the preferred and usual lifestyle of the subject. (Periodic abstinence [e.g., calendar, ovulation, symptothermal, postovulation methods] and withdrawal are not acceptable contraception methods.)",
            "criterions": [
                {
                    "exact_snippets": "Agree to practice true abstinence when this is in line with the preferred and usual lifestyle of the subject.",
                    "criterion": "true abstinence",
                    "requirements": [
                        {
                            "requirement_type": "agreement to practice",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "consistency with lifestyle",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Periodic abstinence [e.g., calendar, ovulation, symptothermal, postovulation methods] and withdrawal are not acceptable contraception methods.",
                    "criterion": "contraception methods",
                    "requirements": [
                        {
                            "requirement_type": "acceptability",
                            "expected_value": {
                                "operator": "!=",
                                "value": 1,
                                "unit": "periodic abstinence or withdrawal"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Surgically sterile (e.g., undergone a hysterectomy or bilateral oophorectomy), or",
            "criterions": [
                {
                    "exact_snippets": "Surgically sterile (e.g., undergone a hysterectomy or bilateral oophorectomy)",
                    "criterion": "surgical sterility",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "undergone a hysterectomy",
                    "criterion": "hysterectomy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "bilateral oophorectomy",
                    "criterion": "bilateral oophorectomy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Female patients must meet one of the following:",
            "criterions": [
                {
                    "exact_snippets": "Female patients",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "female"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Must also adhere to the guidelines of any study-specific pregnancy prevention program, if applicable, OR",
            "criterions": [
                {
                    "exact_snippets": "adhere to the guidelines of any study-specific pregnancy prevention program, if applicable",
                    "criterion": "adherence to study-specific pregnancy prevention program",
                    "requirements": [
                        {
                            "requirement_type": "adherence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "applicability",
                            "expected_value": "if applicable"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Clinical diagnosis of oral cavity squamous cell cancer.",
            "criterions": [
                {
                    "exact_snippets": "Clinical diagnosis of oral cavity squamous cell cancer",
                    "criterion": "oral cavity squamous cell cancer",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "diagnosis_method",
                            "expected_value": "clinical"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Complete Blood Count (CBC)/differential obtained within 14 calendar days prior to registration, with adequate bone marrow function defined as follows:",
            "criterions": [
                {
                    "exact_snippets": "Complete Blood Count (CBC)/differential obtained within 14 calendar days prior to registration",
                    "criterion": "Complete Blood Count (CBC)/differential",
                    "requirements": [
                        {
                            "requirement_type": "timing",
                            "expected_value": "within 14 calendar days prior to registration"
                        }
                    ]
                },
                {
                    "exact_snippets": "adequate bone marrow function defined as follows",
                    "criterion": "bone marrow function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* New diagnosis of oral SCC, new second primary, or recurrent oral SCC following a minimum remission of 6 months following previous definite surgery",
            "criterions": [
                {
                    "exact_snippets": "New diagnosis of oral SCC",
                    "criterion": "oral squamous cell carcinoma (SCC) diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis_status",
                            "expected_value": "new"
                        }
                    ]
                },
                {
                    "exact_snippets": "new second primary",
                    "criterion": "second primary oral squamous cell carcinoma (SCC)",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis_status",
                            "expected_value": "new second primary"
                        }
                    ]
                },
                {
                    "exact_snippets": "recurrent oral SCC following a minimum remission of 6 months following previous definite surgery",
                    "criterion": "recurrent oral squamous cell carcinoma (SCC)",
                    "requirements": [
                        {
                            "requirement_type": "recurrence_status",
                            "expected_value": "recurrent"
                        },
                        {
                            "requirement_type": "remission_duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 6,
                                "unit": "months"
                            }
                        },
                        {
                            "requirement_type": "prior_treatment",
                            "expected_value": "definite surgery"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Potassium: > 3 mmol/L or < 6 mmol/L;",
            "criterions": [
                {
                    "exact_snippets": "Potassium: > 3 mmol/L or < 6 mmol/L",
                    "criterion": "potassium level",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">",
                                        "value": 3,
                                        "unit": "mmol/L"
                                    },
                                    {
                                        "operator": "<",
                                        "value": 6,
                                        "unit": "mmol/L"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Absolute neutrophil count (ANC) ≥ 1,500 cells/mm^3;",
            "criterions": [
                {
                    "exact_snippets": "Absolute neutrophil count (ANC) ≥ 1,500 cells/mm^3",
                    "criterion": "absolute neutrophil count (ANC)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1500,
                                "unit": "cells/mm^3"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Postmenopausal for at least one year before the screening visit, or",
            "criterions": [
                {
                    "exact_snippets": "Postmenopausal for at least one year before the screening visit",
                    "criterion": "menopausal status",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "postmenopausal"
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "year"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patient can start study agent administration but histological confirmation of squamous cell cancer (SCC) of the oral cavity (or histologic variants of SCC) by the pathologist must happen within 7 days of registration in order to continue study agent administration.",
            "criterions": [
                {
                    "exact_snippets": "histological confirmation of squamous cell cancer (SCC) of the oral cavity (or histologic variants of SCC) by the pathologist must happen within 7 days of registration",
                    "criterion": "histological confirmation of squamous cell cancer (SCC) of the oral cavity or histologic variants",
                    "requirements": [
                        {
                            "requirement_type": "confirmation",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "time from registration to confirmation",
                            "expected_value": {
                                "operator": "<=",
                                "value": 7,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Sodium: > 130 mmol/L or < 155 mmol/L.",
            "criterions": [
                {
                    "exact_snippets": "Sodium: > 130 mmol/L or < 155 mmol/L.",
                    "criterion": "sodium level",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">",
                                        "value": 130,
                                        "unit": "mmol/L"
                                    },
                                    {
                                        "operator": "<",
                                        "value": 155,
                                        "unit": "mmol/L"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Gastric tube study agent administration is permissible.",
            "criterions": [
                {
                    "exact_snippets": "Gastric tube study agent administration is permissible",
                    "criterion": "gastric tube study agent administration",
                    "requirements": [
                        {
                            "requirement_type": "permissibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Glucose: > 40 mg/dl or < 250 mg/dl;",
            "criterions": [
                {
                    "exact_snippets": "Glucose: > 40 mg/dl or < 250 mg/dl",
                    "criterion": "glucose level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">",
                                        "value": 40,
                                        "unit": "mg/dl"
                                    },
                                    {
                                        "operator": "<",
                                        "value": 250,
                                        "unit": "mg/dl"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) ≤ 3 x the institutional ULN within 14 calendar days prior to registration",
            "criterions": [
                {
                    "exact_snippets": "Aspartate aminotransferase (AST) ... ≤ 3 x the institutional ULN within 14 calendar days prior to registration",
                    "criterion": "aspartate aminotransferase (AST) level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "x institutional ULN"
                            }
                        },
                        {
                            "requirement_type": "timeframe",
                            "expected_value": "within 14 calendar days prior to registration"
                        }
                    ]
                },
                {
                    "exact_snippets": "alanine aminotransferase (ALT) ≤ 3 x the institutional ULN within 14 calendar days prior to registration",
                    "criterion": "alanine aminotransferase (ALT) level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "x institutional ULN"
                            }
                        },
                        {
                            "requirement_type": "timeframe",
                            "expected_value": "within 14 calendar days prior to registration"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History and physical examination by an otolaryngologist and medical oncologist within 14 calendar days of study registration",
            "criterions": [
                {
                    "exact_snippets": "History and physical examination by an otolaryngologist ... within 14 calendar days of study registration",
                    "criterion": "history and physical examination by an otolaryngologist",
                    "requirements": [
                        {
                            "requirement_type": "performed_within_days_of_registration",
                            "expected_value": {
                                "operator": "<=",
                                "value": 14,
                                "unit": "days"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "History and physical examination by ... medical oncologist within 14 calendar days of study registration",
                    "criterion": "history and physical examination by a medical oncologist",
                    "requirements": [
                        {
                            "requirement_type": "performed_within_days_of_registration",
                            "expected_value": {
                                "operator": "<=",
                                "value": 14,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* If the subject is of childbearing potential (defined as not satisfying either of the above two criteria), agree to practice two acceptable methods of contraception (combination methods requires use of two of the following: diaphragm with spermicide, cervical cap with spermicide, contraceptive sponge, male or female condom, hormonal contraceptive) from the time of signing of the informed consent form through 90 days after the last dose of study agent, AND",
            "criterions": [
                {
                    "exact_snippets": "subject is of childbearing potential (defined as not satisfying either of the above two criteria)",
                    "criterion": "childbearing potential",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "agree to practice two acceptable methods of contraception (combination methods requires use of two of the following: diaphragm with spermicide, cervical cap with spermicide, contraceptive sponge, male or female condom, hormonal contraceptive) from the time of signing of the informed consent form through 90 days after the last dose of study agent",
                    "criterion": "contraception use",
                    "requirements": [
                        {
                            "requirement_type": "number of methods",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "methods"
                            }
                        },
                        {
                            "requirement_type": "method type",
                            "expected_value": [
                                "diaphragm with spermicide",
                                "cervical cap with spermicide",
                                "contraceptive sponge",
                                "male condom",
                                "female condom",
                                "hormonal contraceptive"
                            ]
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": "from the time of signing of the informed consent form through 90 days after the last dose of study agent"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Platelets ≥ 100,000 cells/mm^3;",
            "criterions": [
                {
                    "exact_snippets": "Platelets ≥ 100,000 cells/mm^3",
                    "criterion": "platelet count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 100000,
                                "unit": "cells/mm^3"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Magnesium, calcium, glucose, potassium, and sodium within 14 calendar days prior to registration, with the following required parameters:",
            "criterions": [
                {
                    "exact_snippets": "Magnesium ... within 14 calendar days prior to registration",
                    "criterion": "magnesium level",
                    "requirements": [
                        {
                            "requirement_type": "time frame",
                            "expected_value": "within 14 calendar days prior to registration"
                        }
                    ]
                },
                {
                    "exact_snippets": "calcium ... within 14 calendar days prior to registration",
                    "criterion": "calcium level",
                    "requirements": [
                        {
                            "requirement_type": "time frame",
                            "expected_value": "within 14 calendar days prior to registration"
                        }
                    ]
                },
                {
                    "exact_snippets": "glucose ... within 14 calendar days prior to registration",
                    "criterion": "glucose level",
                    "requirements": [
                        {
                            "requirement_type": "time frame",
                            "expected_value": "within 14 calendar days prior to registration"
                        }
                    ]
                },
                {
                    "exact_snippets": "potassium ... within 14 calendar days prior to registration",
                    "criterion": "potassium level",
                    "requirements": [
                        {
                            "requirement_type": "time frame",
                            "expected_value": "within 14 calendar days prior to registration"
                        }
                    ]
                },
                {
                    "exact_snippets": "sodium ... within 14 calendar days prior to registration",
                    "criterion": "sodium level",
                    "requirements": [
                        {
                            "requirement_type": "time frame",
                            "expected_value": "within 14 calendar days prior to registration"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Calcium: > 7 mg/dl or < 12.5 mg/dl;",
            "criterions": [
                {
                    "exact_snippets": "Calcium: > 7 mg/dl or < 12.5 mg/dl",
                    "criterion": "calcium level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">",
                                        "value": 7,
                                        "unit": "mg/dl"
                                    },
                                    {
                                        "operator": "<",
                                        "value": 12.5,
                                        "unit": "mg/dl"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Total bilirubin < 2 x the institutional upper limit of normal (ULN) within 14 calendar days prior to registration",
            "criterions": [
                {
                    "exact_snippets": "Total bilirubin < 2 x the institutional upper limit of normal (ULN) within 14 calendar days prior to registration",
                    "criterion": "total bilirubin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 2,
                                "unit": "x ULN"
                            }
                        },
                        {
                            "requirement_type": "time frame",
                            "expected_value": "within 14 calendar days prior to registration"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Adequate renal and hepatic function within 14 calendar days prior to registration, defined as follows:",
            "criterions": [
                {
                    "exact_snippets": "Adequate renal ... function within 14 calendar days prior to registration",
                    "criterion": "renal function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "timeframe",
                            "expected_value": "within 14 calendar days prior to registration"
                        }
                    ]
                },
                {
                    "exact_snippets": "Adequate ... hepatic function within 14 calendar days prior to registration",
                    "criterion": "hepatic function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "timeframe",
                            "expected_value": "within 14 calendar days prior to registration"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Clinical stage II-IVA (as defined by the American Joint Committee on Cancer, 8th Edition [see Amin, 2017]) and amenable to surgical resection",
            "criterions": [
                {
                    "exact_snippets": "Clinical stage II-IVA (as defined by the American Joint Committee on Cancer, 8th Edition [see Amin, 2017])",
                    "criterion": "clinical stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": [
                                "II",
                                "III",
                                "IVA"
                            ]
                        },
                        {
                            "requirement_type": "staging_system",
                            "expected_value": "American Joint Committee on Cancer, 8th Edition"
                        }
                    ]
                },
                {
                    "exact_snippets": "amenable to surgical resection",
                    "criterion": "surgical resection amenability",
                    "requirements": [
                        {
                            "requirement_type": "amenability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Hemoglobin ≥ 8.0 g/dl (Note: The use of transfusion or other intervention to achieve Hgb ≥ 8.0 g/dl is acceptable.);",
            "criterions": [
                {
                    "exact_snippets": "Hemoglobin ≥ 8.0 g/dl",
                    "criterion": "hemoglobin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 8.0,
                                "unit": "g/dl"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Magnesium: > 0.9 mg/dl or < 3 mg/dl;",
            "criterions": [
                {
                    "exact_snippets": "Magnesium: > 0.9 mg/dl or < 3 mg/dl",
                    "criterion": "magnesium level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">",
                                        "value": 0.9,
                                        "unit": "mg/dl"
                                    },
                                    {
                                        "operator": "<",
                                        "value": 3,
                                        "unit": "mg/dl"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients must provide study-specific informed consent prior to study entry.",
            "criterions": [
                {
                    "exact_snippets": "Patients must provide study-specific informed consent prior to study entry.",
                    "criterion": "informed consent",
                    "requirements": [
                        {
                            "requirement_type": "provision",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "prior to study entry"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients must be deemed able to comply with the study plan.",
            "criterions": [
                {
                    "exact_snippets": "Patients must be deemed able to comply with the study plan.",
                    "criterion": "ability to comply with the study plan",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patient must receive administration of study agent for a minimum of 7 days",
            "criterions": [
                {
                    "exact_snippets": "Patient must receive administration of study agent for a minimum of 7 days",
                    "criterion": "administration of study agent",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 7,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Zubrod Score/Eastern Cooperative Oncology Group (ECOG) Performance status < 2.",
            "criterions": [
                {
                    "exact_snippets": "Zubrod Score/Eastern Cooperative Oncology Group (ECOG) Performance status < 2",
                    "criterion": "Zubrod Score/ECOG Performance status",
                    "requirements": [
                        {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": "<",
                                "value": 2,
                                "unit": "N/A"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Male patients, even if surgically sterilized (e.g., status post vasectomy), must agree to one of the following:",
            "criterions": [
                {
                    "exact_snippets": "Male patients",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "male"
                        }
                    ]
                },
                {
                    "exact_snippets": "even if surgically sterilized (e.g., status post vasectomy)",
                    "criterion": "surgical sterilization status",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "allowed"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Agree to practice true abstinence when this is in line with the preferred and usual lifestyle of the subject. (Periodic abstinence [e.g., calendar, ovulation, symptothermal, post ovulation methods] and withdrawal are not acceptable methods of contraception.)",
            "criterions": [
                {
                    "exact_snippets": "Agree to practice true abstinence",
                    "criterion": "sexual abstinence",
                    "requirements": [
                        {
                            "requirement_type": "agreement to practice",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "type of abstinence",
                            "expected_value": "true abstinence"
                        }
                    ]
                },
                {
                    "exact_snippets": "when this is in line with the preferred and usual lifestyle of the subject",
                    "criterion": "abstinence as usual lifestyle",
                    "requirements": [
                        {
                            "requirement_type": "consistency with lifestyle",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Periodic abstinence [e.g., calendar, ovulation, symptothermal, post ovulation methods] and withdrawal are not acceptable methods of contraception",
                    "criterion": "contraception method",
                    "requirements": [
                        {
                            "requirement_type": "excluded methods",
                            "expected_value": [
                                "periodic abstinence",
                                "calendar method",
                                "ovulation method",
                                "symptothermal method",
                                "post ovulation method",
                                "withdrawal"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "o Serum creatinine < 1.5 mg/dl or creatinine clearance (CCr) ≥ 50 ml/min within 14 calendar days prior to registration, determined by 24-hour collection or estimated by Cockcroft-Gault formula: CCr male = [(140 - age) x (wt in kg)] [(Serum Cr mg/dl) x (72)] CCr female = 0.85 x (CrCl male)",
            "criterions": [
                {
                    "exact_snippets": "Serum creatinine < 1.5 mg/dl ... within 14 calendar days prior to registration",
                    "criterion": "serum creatinine",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 1.5,
                                "unit": "mg/dl"
                            }
                        },
                        {
                            "requirement_type": "timeframe",
                            "expected_value": "within 14 calendar days prior to registration"
                        }
                    ]
                },
                {
                    "exact_snippets": "creatinine clearance (CCr) ≥ 50 ml/min within 14 calendar days prior to registration, determined by 24-hour collection or estimated by Cockcroft-Gault formula",
                    "criterion": "creatinine clearance (CCr)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 50,
                                "unit": "ml/min"
                            }
                        },
                        {
                            "requirement_type": "timeframe",
                            "expected_value": "within 14 calendar days prior to registration"
                        },
                        {
                            "requirement_type": "determination method",
                            "expected_value": [
                                "24-hour collection",
                                "estimated by Cockcroft-Gault formula"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Pregnant or lactating women are ineligible due to unforeseeable risks to embryo or fetus.",
            "criterions": [
                {
                    "exact_snippets": "Pregnant ... are ineligible",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "lactating women are ineligible",
                    "criterion": "lactation status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Planned subtotal or debulking surgery, as determined by enrolling physician determination, is not permissible.",
            "criterions": [
                {
                    "exact_snippets": "Planned subtotal or debulking surgery ... is not permissible",
                    "criterion": "planned subtotal or debulking surgery",
                    "requirements": [
                        {
                            "requirement_type": "planned",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of active liver disease",
            "criterions": [
                {
                    "exact_snippets": "History of active liver disease",
                    "criterion": "active liver disease",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior radiotherapy for oral SCC is permissible if disease free for 1 year since prior oral cancer treatment and free of significant late radiation effects.",
            "criterions": [
                {
                    "exact_snippets": "Prior radiotherapy for oral SCC is permissible if disease free for 1 year since prior oral cancer treatment",
                    "criterion": "disease free status since prior oral cancer treatment",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "year"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "free of significant late radiation effects",
                    "criterion": "significant late radiation effects",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Severe active comorbidity such as uncontrolled cardiac disease, infection, severe Chronic Obstructive Pulmonary Disease (COPD).",
            "criterions": [
                {
                    "exact_snippets": "Severe active comorbidity such as uncontrolled cardiac disease",
                    "criterion": "cardiac disease",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "uncontrolled"
                        }
                    ]
                },
                {
                    "exact_snippets": "Severe active comorbidity such as ... infection",
                    "criterion": "infection",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        },
                        {
                            "requirement_type": "severity",
                            "expected_value": "severe"
                        }
                    ]
                },
                {
                    "exact_snippets": "Severe active comorbidity such as ... severe Chronic Obstructive Pulmonary Disease (COPD)",
                    "criterion": "Chronic Obstructive Pulmonary Disease (COPD)",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "severe"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior systemic chemotherapy for oral SCC; note that prior chemotherapy for a different cancer is allowable.",
            "criterions": [
                {
                    "exact_snippets": "Prior systemic chemotherapy for oral SCC",
                    "criterion": "prior systemic chemotherapy for oral SCC",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "prior chemotherapy for a different cancer is allowable",
                    "criterion": "prior chemotherapy for a different cancer",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Concurrent use of any medicinal botanical, natural, or other herbal compound/s that the study PI believes could potentially impact the results/objectives of this study",
            "criterions": [
                {
                    "exact_snippets": "Concurrent use of any medicinal botanical, natural, or other herbal compound/s",
                    "criterion": "use of medicinal botanical, natural, or other herbal compounds",
                    "requirements": [
                        {
                            "requirement_type": "concurrent use",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "that the study PI believes could potentially impact the results/objectives of this study",
                    "criterion": "potential impact of compounds on study results/objectives (as judged by PI)",
                    "requirements": [
                        {
                            "requirement_type": "potential impact (PI judgment)",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}